By Plenary Sessions: Irja Lutsar
Total Sessions: 3
Fully Profiled: 3
2024-10-23
15th Riigikogu, 4th sitting, plenary session
It advocates increasing market competition to lower drug prices and shortening supply chains to ensure the best possible price. Concern is expressed that granting broad import rights could lead to the nationalization of one-third of the pharmaceutical market and increase hospitals' administrative costs and bureaucracy. It prefers solutions that improve accessibility without significantly restricting private sector activity.
2024-10-16
15th Riigikogu, 4th session, plenary sitting
Economic positions focus on the targeted distribution of state support to ensure the accessibility and efficiency of services. Support is given to a funding formula that utilizes a floor and ceiling mechanism, ensuring that smaller municipalities receive a sufficient amount for service provision. The right of local government units (LGUs) to charge a co-payment for services was also addressed.
2024-10-10
Fifteenth Riigikogu, Fourth sitting, plenary session.
Not enough data